← Leaderboards
Todd C Hankinson
University Of Colorado Denver
$311,000
Attributed
$311,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $77.8K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$311,000 · 2
By mechanism
R03$311,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Jean Marie Mulcahy Levy$2,536,082
- Eric W Prince$73,868
Others in their field
Other Emerging Leaders on “Cytokine”
- Thomas Denny · Duke University$22,999,550
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Gary Fanger · Rise Therapeutics, Llc$12,156,047
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$9,841,960
Research focus
CytokineEconomic BurdenCognitiveCyst FluidChildhood CraniopharyngiomaDisabilityChildChronic DiseaseColoradoCystAcuteAnimal ModelBasic ScienceAnimalsActivities Of Daily LivingBlindnessChildhood Brain NeoplasmChronicChildhoodCollaborationsCtnnb1 GeneCellsAwardEnvironment
Grant awards (4)
Advancing Treatment for Pediatric Craniopharyngioma (ATPC); in vivo Tocilizumab Measurement$77,750
R03 · FY2020 · CA · contact PI
Advancing Treatment for Pediatric Craniopharyngioma (ATPC); in vivo Tocilizumab Measurement$77,750
R03 · FY2019 · CA · contact PI
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu$77,750
R03 · FY2018 · CA · contact PI
Advancing Treatments for Pediatric Craniopharyngioma (ATPC): Preliminary Assessment of the Cyst Fluid Inflammatory Milieu$77,750
R03 · FY2017 · CA · contact PI